Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mind Medicine (MindMed) Inc
Total Current Assets
Mind Medicine (MindMed) Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Total Current Assets
$215.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
63%
|
CAGR 10-Years
101%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Total Current Assets
$6.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Current Assets
CA$524.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
27%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Total Current Assets
CA$449.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Current Assets
$944.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
100%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Total Current Assets
CA$394.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
Mind Medicine (MindMed) Inc
Glance View
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.
See Also
What is Mind Medicine (MindMed) Inc's Total Current Assets?
Total Current Assets
215.8m
USD
Based on the financial report for Sep 30, 2025, Mind Medicine (MindMed) Inc's Total Current Assets amounts to 215.8m USD.
What is Mind Medicine (MindMed) Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
101%
Over the last year, the Total Current Assets growth was -28%. The average annual Total Current Assets growth rates for Mind Medicine (MindMed) Inc have been 11% over the past three years , 63% over the past five years , and 101% over the past ten years .
